Predictive biomarkers can indicate if a patient will respond to a particular therapy. Dr. Lauren Harshman discusses if researchers know of any biomarkers for kidney cancer patients taking PD1 inhibitor drugs.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
